Holmusk, a Singapore-based digital health and data analytics company, closed a US$9.75m Pre-Series A financing.
The round included funding from Heritas Venture Fund as well as participation from new and existing investors.
The funds will allow the company to expand its footprint in USA and Europe.
Led by Nawal Roy, Founder and CEO, Holmusk leverages technology and data science to accelerate research and improve outcomes for people with chronic diseases and behavioral health disorders. Partnering with Pharma and healthcare providers, the company informs predictive algorithms and provides actionable insights for personalized medicine through its proprietary modelling platform.
Alongside this, Holmusk has an innovative digital health platform for patient engagement.
The company is also expanding its assets in behavioral health. Having acquired MindLinc, a behavioral health EHR, it now holds one of the largest behavioral health databases in the world. Combining system dynamics with deep learning neural networks and quantitative systems pharmacology, Holmusk is developing MindLinc 2.0 which will include predictive disease models based on longitudinal patient data.
Based out of Singapore, the company also has offices in the US, UK and Malaysia.